![](/img/cover-not-exists.png)
Efficacy and safety of alirocumab 150 mg every 4 weeks in hypercholesterolemic patients on non-statin lipid-lowering therapy or lowest strength dose of statin: ODYSSEY NIPPON
Teramoto, Tamio, Kiyosue, Arihiro, Ishigaki, Yasushi, Harada-Shiba, Mariko, Kawabata, Yumiko, Ozaki, Asuka, Baccara-Dinet, Marie T., Sata, MasatakaLanguage:
english
Journal:
Journal of Cardiology
DOI:
10.1016/j.jjcc.2018.10.004
Date:
November, 2018
File:
PDF, 1.08 MB
english, 2018